The average 12-month price target on the company stock within the last year is $60.67, according to the report. The company has a one-year high of $62.83 and a one-year low of $40.
More articles on transactions and valuation issues:
AmSurg CAO sells nearly 9k shares
5 recent ASC company acquisitions & partnerships
Park Hill – MOB and ASC open in Fort Worth: 8 key points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
